The pharmacist’s role in supporting remission of type 2 diabetes

Ed J. Stein, PharmD, MPH, DipACLM, consulting pharmacist, Modern Health Goals

“Pharmacists are often the most accessible members of the healthcare team (…), and this is another touchpoint where patients can work with healthcare providers towards the remission of their type 2 diabetes.”

— Dr. Stein

How pharmacists expand access to lifestyle medicine in type 2 diabetes care

Pharmacists play a critical yet often overlooked role in the care of people with type 2 diabetes. In this expert interview, Dr. Stein explores how pharmacists — particularly those working in community and independent pharmacy settings — are uniquely positioned to support evidence-based lifestyle medicine as part of an interprofessional healthcare team. With most people in the U.S. living within minutes of a pharmacy, these professionals represent one of the most accessible touchpoints in the healthcare system.

Dr. Stein challenges the misconception that lifestyle medicine conflicts with the pharmacist’s role. Instead, he highlights how therapeutic lifestyle interventions create new opportunities for pharmacists to engage patients, provide education, help reduce medication dependence, and support the restoration of health. By shifting the focus from long-term disease management to the possibility of remission, pharmacists can help reframe the initial diagnosis of type 2 diabetes, offering patients a more hopeful, collaborative path forward.

The conversation also explores how pharmacists can empower patients by emphasizing shared decision-making and behavior change. When patients understand that lifestyle medicine places them at the center of care — giving them tools to influence their own outcomes — they are more likely to engage, sustain change, and experience improved health. Dr. Stein underscores how integrating lifestyle medicine into pharmacy practice benefits patients, clinicians, and communities alike.

More Expert Interviews

Eduardo J. Sanchez, MD, MPH, FAHA, chief medical officer for prevention, American Heart Association

Strategy for diabetes remission

Josie Bidwell, DNP, RN, FNP-C, DipACLM, FACLM, professor & clinical director, Department of Preventive Director, Office of Well-being, University of Mississippi Medical Center

Rural health solutions

Mahima Gulati, MD, FACE, MSc, DipABLM, FACLM, board certified endocrinologist, UConn Health

The science of remission

Michelle McMacken, MD, FACP, DipABLM, executive director, Nutrition and Lifestyle Medicine, NYC Health + Hospitals

Scaling lifestyle medicine

Wayne Dysinger, MD, MPH, DipABLM, FACLM, chief medical officer, Blue Zones Health

Primary care, reimbursement, and remission

Ori Kochavi, associate chief administration officer, The Permanente Medical Group

The power of lifestyle medicine